A real life, multicentre study assessing tolerability, adherence and basic demographics in patients treated with dimethyl fumarate for multiple sclerosis .
Phase of Trial: Phase IV
Latest Information Update: 17 Nov 2016
At a glance
- Drugs Dimethyl fumarate (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- 17 Nov 2016 New trial record